Clinical Trial Update: Screening for Amyloidosis Before Aortic Valve Elective Replacement

View source ↗

Summary

Charite University in Berlin is screening for amyloidosis in patients undergoing elective aortic valve replacement; the trial (NCT04869631) is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Aortic Valve Stenosis

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Amyloidosis, Aortic Valve Stenosis | Status: ACTIVE_NOT_RECRUITING